Vanguard Group Inc Nutri Band Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NTRB
# of Institutions
20Shares Held
268KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA70.4KShares$390,8080.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny20.7KShares$115,0010.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$95,8260.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA16KShares$88,8770.0% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY10.9KShares$60,6830.0% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $43.3M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...